AgNOR status in Down's syndrome infants and a plausible phenotype formation hypothesis

Micron

Volumn 40, Issue 5-6, 2009, Pages 511-518

  Demirtas, Halil ^a  

^a ERCIYES UNIVERSITY   (Turkey)

Author keywords

'Wasted energy hypothesis'; AgNOR; AgNOR proteins; Down's syndrome phenotype formation hypothesis; NORs; Trisomy 21

Indexed keywords

'WASTED ENERGY HYPOTHESIS'; AGNOR; AGNOR-PROTEINS; DOWN'S SYNDROME PHENOTYPE FORMATION HYPOTHESIS; NORS; TRISOMY 21;

CYTOLOGY; DIELECTRIC RELAXATION; METABOLISM; NUCLEIC ACIDS; PROTEINS; RNA; SILVER; SUPRAMOLECULAR CHEMISTRY;

CHROMOSOMES;

CELL NUCLEUS ANTIGEN; NUCLEOLAR ORGANIZER REGION ASSOCIATED PROTEINS; RIBOSOME PROTEIN; RIBOSOME RNA;

BIOSYNTHESIS; CHEMISTRY; CHROMOSOME; DOWN SYNDROME; GENE DOSAGE; HUMAN; INFANT; PATHOLOGY; REVIEW;

ANTIGENS, NUCLEAR; CHROMOSOMES; DOWN SYNDROME; GENE DOSAGE; HUMANS; INFANT; RIBOSOMAL PROTEINS; RNA, RIBOSOMAL;

EID: 67349231662     PISSN: 09684328     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.micron.2009.02.014     Document Type: Review

References (138)

1. Aguinaga M., Razo G., Castro J., and Mayen-Molina D.G. Prenatal diagnosis of trisomy 21 without the Down syndrome phenotype. Prenatal Diag. 26 12 (2006) 1168-1171
2. Allen E.G., Freeman S.B., Druschel C., Hobbs C.A., O'Leary L.A., Romitti P.A., Royle M.H., Torfs C.P., and Sherman S.L. Maternal age and risk for trisomy 21 assessed by the origin of chromosome nondisjunction: a report from the Atlanta and National Down Syndrome Projects. Hum. Genet. 125 1 (2009) 41-52
3. Allison D.B., Gomez J.E., Heshka S., Babbitt R.L., Geliebter A., Kreibich K., and Heymsfield S.B. Decreased resting metabolic-rate among persons with Down-syndrome. Int. J. Obesity 19 12 (1995) 858-861
4. Andersen J.S., Lyon C.E., Fox A.H., Leung A.K.L., Lam Y.W., Steen H., Mann M., and Lamond A.I. Directed proteomic analysis of the human nucleolus. Curr. Biol. 12 1 (2002) 1-11
5. Andersen J.S., Lam Y.W., Leung A.K., Ong S.E., Lyon C.E., Lamond A.I., and Mann M. Nucleolar proteome dynamics. Nature 433 7021 (2005) 77-83
6. Annerén G., Wahlström J., and Tommerup N. Marker chromosomes in parents to children with Down's syndrome. Clin. Genet. 25 2 (1984) 140-147
7. Antonarakis S.E., Avramopoulos D., Blouin J.L., Talbot Jr. C.C., and Schinzel A.A. Mitotic errors in somatic cells cause trisomy 21 in about 4.5% of cases and are not associated with advanced maternal age. Nat. Genet. 3 2 (1993) 146-150
8. Antonarakis S.E., and Epstein C.J. The challenge of Down syndrome. Trends Mol. Med. 12 10 (2006) 473-479
9. Arbuzova S., Hutchin T., and Cuckle H. Mitochondrial dysfunction and Down's syndrome. Bioessays 24 8 (2002) 681-684
10. Arora B., Kumar S., and Jain R. Morphometric evaluation of nucleolar organiser regions in reactive and neoplastic lymph node lesions. J. Indian Med. Assoc. 104 1 (2006) 16-18
11. Bambrick L.L., and Fiskum G. Mitochondrial dysfunction in mouse trisomy 16 brain. Brain Res. 1188 (2008) 9-16
12. Bayless-Underwood L., Cho S., Ward B., and Robinson A. Two cases of prenatal diagnosis of a satellited Yq chromosome. Clin. Genet. 24 5 (1983) 359-364
13. Benn P.A., and Perle M.A. In: Rooney D.E., and Czepulkowski B.H. (Eds). Chromosome Staining and Banding Techniques, Human Cytogenetics, Constitutional Analysis, A practical approach, vol. I (1992), Oxford University Press, Oxford 91-118
14. Bernert G., Fountoulakis M., and Lubec G. Manifold decreased protein levels of matrin 3, reduced motor protein HMP and hlark in fetal Down's syndrome brain. Proteomics 2 12 (2002) 1752-1757
15. Bersu E.T., Ahmad F.J., Schwei M.J., and Baas P.W. Cytoplasmic abnormalities in cultured cerebellar neurons from the trisomy 16 mouse. Brain Res. Dev. Brain Res. 109 1 (1998) 115-120
16. Boisvert F.M., van Koningsbruggen S., Navascues J., and Lamond A.I. The multifunctional nucleolus. Nat. Rev. Mol. Cell. Biol. 8 7 (2007) 574-585
17. Borsatto B., and Smith M. Reduction of the activity of ribosomal genes with age in Down's syndrome. Gerontology 42 3 (1996) 147-154
18. Bouteille M., and Hernandez-Verdun D. Localization of a gene: the nucleolar organizer. Biomedicine 30 6 (1979) 282-287
19. Boyne J.R., and Whitehouse A. Nucleolar trafficking is essential for nuclear export of intronless herpesvirus mRNA. Proc. Natl. Acad. Sci. U.S.A. 103 41 (2006) 15190-15195
20. Busciglio J., Pelsman A., Wong C., Pigino G., Yuan M., Mori H., and Yankner B.A. Altered metabolism of the amyloid beta precursor protein is associated with mitochondrial dysfunction in Down's syndrome. Neuron 33 5 (2002) 677-688
21. Buys C.H., Osinga J., and Anders G.J. Age-dependent variability of ribosomal RNA-gene activity in man as determined from frequencies of silver staining nucleolus organizing regions on metaphase chromosomes of lymphocytes and fibroblasts. Mech. Ageing Dev. 11 1 (1979) 55-75
22. Caburet S., Conti C., Schurra C., Lebofsky R., Edelstein S.J., and Bensimon A. Human ribosomal RNA gene arrays display a broad range of palindromic structures. Genome Res. 15 (2005) 1079-1085
23. Canfield M.A., Honein M.A., Yuskiv N., Xing J., Mai C.T., Collins J.S., Devine O., Petrini J., Ramadhani T.A., Hobbs C.A., and Kirby R.S. National estimates and race/ethnic-specific variation of selected birth defects in the United States, 1999-2001. Birth Defects Res. A: Clin. Mol. Teratol. 76 11 (2006) 747-756
24. Chang K.T., and Min K.T. Drosophila melanogaster homolog of Down syndrome critical region 1 is critical for mitochondrial function. Nat. Neurosci. 8 11 (2005) 1577-1585
25. Cheon M.S., Dierssen M., Kim S.H., and Lubec G. Protein expression of BACE1, BACE2 and APP in Down syndrome brains. Amino Acids 35 2 (2008) 339-343
26. Cocchi G., Mastrocola M., Capelli M., Bastelli A., Vitali F., and Corvaglia L. Immunological patterns in young children with Down syndrome: is there a temporal trend?. Acta Paediatr. 96 10 (2007) 1479-1482
27. Conti A., Fabbrini F., D'Agostino P., Negri R., Greco D., Genesio R., D'Armiento M., Olla C., Paladini D., Zannini M., and Nitsch L. Altered expression of mitochondrial and extracellular matrix genes in the heart of human fetuses with chromosome 21 trisomy. BMC Genomics 8 (2007) 268-282
28. Cossarizza A., Monti D., Montagnani G., Ortolani C., Masi M., Zannotti M., and Franceschi C. Precocious aging of the immune system in Down syndrome: alteration of B lymphocytes, T-lymphocyte subsets, and cells with natural killer markers. Am. J. Med. Genet. Suppl. 7 (1990) 213-218
29. Couté Y., Burgess J.A., Diaz J.J., Chichester C., Lisacek F., Greco A., and Sanchez J.C. Deciphering the human nucleolar proteome. Mass Spectrom. Rev. 25 2 (2006) 215-234
30. Cucer N., Imamoglu N., Tozak H., Demirtas H., Sarac F., Tatlisen A., and Oztürk F. Two-dimensional AgNOR evaluation as a prognostic variable in urinary bladder carcinoma: a different approach via total AgNOR area/nucleus area per cell. Micron 38 6 (2007) 674-679
31. da Rosa Utiyama S.R., Nisihara R.M., Nass F.R., Oliveira N.P., Fiedler P.T., and de Messias-Reason I.T. Autoantibodies in patients with Down syndrome: early senescence of the immune system or precocious markers for immunological diseases?. J. Paediatr. Child Health 44 4 (2008) 182-186
32. Das B.C., Rani R., Mitra A.B., and Luthra U.K. The number of silver-staining NORs (rDNA) in lymphocytes of newborns and its relationship to human development. Mech. Ageing Dev. 36 2 (1986) 117-123
33. Dawson-Saunders B., and Trapp R.G. Basic and Clinical Biostatistics (1990), Prentice-Hall International Inc. Englewood Cliffs, New Jersey, USA pp. 21-22
34. Delabar J.M., Theophile D., Rahmani Z., Chettouh Z., Blouin J.L., Prieur M., Noel B., and Sinet P.M. Molecular mapping of twenty-four features of Down syndrome on chromosome 21. Eur. J. Hum. Genet. 1 2 (1993) 114-124
35. Demirtas H. Tibbi Biyoloji ve Genetik Ders Notlari [Courses on Medical Biology and Genetics] (1996), Erciyes Univ. Press, no: 90, Kayseri, Turkey p. 218
36. Demirtas H., Cucer N., Boztosun N., and Ozturk M. Condensed chromatin enhancement in the phytohemagglutinin-stimulated lymphocyte interphase nuclei of two xeroderma pigmentosum patients and artificial chromatin condensation of healthy cell nuclei by UV irradiation (Letter). Clin. Genet. 51 (1997) 137-138
37. Demirtas H., Ceylaner S., and Cucer N. Condensed chromatin enhancement in the phytohemagglutinin-stimulated lymphocyte interphase nuclei of 23 Down syndrome patients (proceeding). Cytogenet. Cell Genet. 77 1-2 (1997) 106
38. Demirtas H., Imamoglu N., Cucer N., Donmez H., Yilmaz A., Candemir Z., and Bokesoy I. NOR (rDNA) expression enhancement in phytohemagglutinin-stimulated lymphocytes of Down syndrome patients. Erciyes U. J. Health Sci. 8 (1999) 24-27
39. Demirtas H., Candemir Z., Cucer N., Imamoglu N., Donmez H., and Bokesoy I. Essay on the nucleoli survey by the alpha- and beta-satellite DNA probes of the acrocentric chromosomes in mitogen-stimulated human lymphocytes. Ann. Genet. Paris 43 (2000) 61-68
40. Demirtas H., Imamoglu N., Donmez H., Cucer N., Yilmaz A., and Candemir Z. Condensed chromatin surface and NORs surface enhancement in mitogen-stimulated lymphocytes of Down syndrome patients. Ann. Genet. Paris 44 (2001) 77-82
41. Denton T.E., Liem S.L., Cheng K.M., and Barrett J.V. The relationship between aging and ribosomal gene activity in humans as evidenced by silver staining. Mech. Ageing Dev. 15 1 (1981) 1-7
42. Derenzini M., Farabegoli F., Pession A., and Novello F. Spatial redistribution of ribosomal chromatin in the fibrillar centre of human circulating lymphocytes after stimulation of transcription. Exp. Cell Res. 170 (1987) 31-41
43. Derenzini M., and Trerè D. Standardization of interphase Ag-NOR measurement by means of an automated image analysis system using lymphocytes as an internal control. J. Pathol. 165 4 (1991) 337-342
44. Derenzini M., and Trerè D. AgNOR proteins as a parameter of the rapidity of cell proliferation. Zentralbl. Pathol. 140 1 (1994) 7-10
45. Derenzini M. The AgNORs. Micron 31 2 (2000) 117-120
46. Derenzini M., Ceccarelli C., Santini D., Taffurelli M., and Treré D. The prognostic value of the AgNOR parameter in human breast cancer depends on the pRb and p53 status. J. Clin. Pathol. 57 7 (2004) 755-761
47. Fernhall B., Figueroa A., Collier S., Goulopoulou S., Giannopoulou I., and Baynard T. Resting metabolic rate is not reduced in obese adults with Down syndrome. Ment. Retard. 43 6 (2005) 391-400
48. Fonatsch C., Nowotny H., Pittermann-Hocker E., Streubel B., Jager U., Valent P., Buchner T., and Lechner K. Amplification of ribosomal RNA genes in acute myeloid leukemia. Gene Chromosome Cancer 32 1 (2001) 11-17
49. Fromont-Racine M., Senger B., Saveanu C., and Fasiolo F. Ribosome assembly in eukaryotes. Gene 313 (2003) 17-42
50. Gardiner K. Transcriptional dysregulation in Down syndrome: prediction for altered protein complex stoichiometries and post-translational modifications, and consequences for learning/behavior genes ELK, CREB, and the estrogen and glucocorticoid receptors. Behav. Genet. 36 3 (2006) 439-453
51. Giuffrè G., Mormandi F., Barresi V., Bordi C., Tuccari G., and Barresi G. Quantity of AgNORs in gastric endocrine carcinoid tumors as a potential prognostic tool. Eur. J. Histochem. 50 1 (2006) 45-50
52. Goodpasture C., and Bloom S.E. Visualization of nucleolar organizer regions in mammalian chromosomes using silver staining. Chromosoma 53 1 (1975) 37-50
53. Greber-Platzer S., Schatzmann-Turhani D., Wollenek G., and Lubec G. Evidence against the current hypothesis of "gene dosage effects" of trisomy 21: ets-2, encoded on chromosome 21" is not overexpressed in hearts of patients with Down Syndrome. Biochem. Biophys. Res. Commun. 254 2 (1999) 395-399
54. Guimera J., Casas C., Estivill X., and Pritchard M. Human minibrain homologue (MNBH/DYRK1): characterization, alternative splicing, differential tissue expression, and overexpression in Down syndrome. Genomics 57 3 (1999) 407-418
55. Hagemeijer A., and Smit E.M. Further evidence that trisomy of band 21q22 is essential for Down's phenotype. Partial trisomy 21. Hum. Genet. 38 1 (1977) 15-23
56. Hamurcu Z., Demirtas H., and Kumandas S. Flow cytometric comparison of RNA content in peripheral blood mononuclear cells of Down syndrome patients and control individuals. Cytometry B: Clin. Cytom. 70 1 (2006) 24-28
57. Hamurcu Z., Demirtas H., Patiroglu T., Kumandas S., Imamoglu N., Ozkul Y., and Donmez-Altuntas H. Age-dependent decreases in mitogen-stimulation level and RNA content in peripheral blood mononuclear cells of Down syndrome patients. Cytometry B: Clin. Cytom. 72 1 (2007) 43-48
58. Hamurcu Z., Demirtas H., Patiroǧlu T., and Kumandas S. Nuclear protein contents in peripheral blood mononuclear cells of trisomy 21 infants. Cytometry B: Clin. Cytom. 74 2 (2008) 128-132
59. Hernandez-Verdun D., and Louvet E. Le nucleole: structure, functions et maladies associées. Medicine/Sciences 20 (2004) 37-44
60. Hernandez-Verdun D. The nucleolus: a model for the organization of nuclear functions. Histochem. Cell Biol. 126 (2006) 135-148
61. Hernandez-Verdun D. Nucleolus: from structure to dynamics. Histochem. Cell Biol. 125 1-2 (2006) 127-137
62. Howell W.M., Denton T.E., and Diamond J.R. Differential staining of the satellite regions of human acrocentric chromosomes. Experientia 31 2 (1975) 260-262
63. Hubbell H.R. Silver staining as an indicator of active ribosomal genes. Stain Technol. 60 5 (1985) 285-294
64. Imamoglu N., Demirtas H., Donmez-Altuntas H., and Ilten A. Higher NORs expression in lymphocyte of trisomy 21 babies/children: in vivo evaluation. Micron 36 (2005) 503-507
65. Imamoglu N., Demirtas H., Donmez-Altuntas H., Hamurcu Z., and Ilten A. NOR expression increase on metaphase chromosomes of Down syndrome lymphocytes in concordance with mitogen concentration in culture medium. Cytometry B: Clin. Cytom. 66 (2005) 36-39
66. Imamoglu N., Demirtas H., and Ilten A. NOR expression increases in interphase lymphocytes of Down syndrome babies/children as AgNOR surface, according to the mitogen concentration in the culture medium. Micron 37 (2006) 129-133
67. Jacobs P.A., Baikie A.G., Court-Brown W.M., and Strong J.A. The somatic chromosomes in mongolism. Lancet 1 7075 (1959) 710-711
68. Jemielity S., Kimura M., Parker K.M., Parker J.D., Cao X., Aviv A., and Keller L. Short telomeres in short-lived males: what are the molecular and evolutionary causes?. Aging Cell 6 2 (2007) 225-233
69. Jenkins E.C., Velinov M.T., Ye L., Gu H., Li S., Jenkins Jr. E.C., Brooks S.S., Pang D., Devenny D.A., Zigman W.B., Schupf N., and Silverman W.P. Telomere shortening in T lymphocytes of older individuals with Down syndrome and dementia. Neurobiol. Aging 27 7 (2006) 941-945
70. Jimenez R., and Burgos M. A study of the Ag-staining significance in mitotic NOR's. Heredity 60 (1988) 125-127
71. John B. The biology of heterochromatin. In: Ram S., and Verma (Eds). Heterochromatin, Molecular and Structural Aspects (1988), Cambridge Univ. Press, New York, NY, USA 1-147
72. Johnson A.W., Lund E., and Dahlberg J. Nuclear export of ribosomal subunits. Trends Biochem. Sci. 27 11 (2002) 580-585
73. Junéra H.R., Masson C., Géraud G., and Hernandez-Verdun D. The three-dimensional organization of ribosomal genes and the architecture of the nucleoli vary with G1, S and G2 phases. J. Cell Sci. 108 11 (1995) 3427-3441
74. Juntes P., and Pogacnik M. Morphometric analysis of AgNORs in tubular and papillary parts of canine mammary gland tumors. Anal. Quant. Cytol. Histol. 22 3 (2000) 185-192
75. Kahlem P. Gene-dosage effect on chromosome 21 transcriptome in trisomy 21: implication in Down syndrome cognitive disorders. Behav. Genet. 36 3 (2006) 416-428
76. Kai Y., Wang C.C., Kishigami S., Kazuki Y., Abe S., Takiguchi M., Shirayoshi Y., Inoue T., Ito H., Wakayama T., and Oshimura M. Enhanced apoptosis during early neuronal differentiation in mouse ES cells with autosomal imbalance. Cell Res. (2008) 305 doi:10. 1038/cr. 2008
77. Korenberg J.R., Chen X.N., Schipper R., Sun Z., Gonsky R., Gerwehr S., Carpenter N., Daumer C., Dignan P., Disteche C., Graham J.M., Hugdins L., McGillivray B., Miyazaki K., Ogasawara N., Park J.P., and Pagon R. Down syndrome phenotypes: the consequences of chromosomal imbalance. Proc. Natl. Acad. Sci. U.S.A. 91 11 (1994) 4997-5001
78. Kosaki R., Kosaki K., Matsushima K., Mitsui N., Matsumoto N., and Ohashi H. Refining chromosomal region critical for Down syndrome-related heart defects with a case of cryptic 21q22.2 duplication. Congenit. Anom. (Kyoto) 45 2 (2005) 62-64
79. Kost M.V., Alimov A.A., Sarafanov A.G., Tikchomirova T.P., Gumeniuk R.R., Timofeeva Mja., and Zelenin A.V. 5S rRNA gene hybridizes to human chromosome 1 at two sites (1q42.11 → q42.13 and 1q43). Cytogenet. Cell Genet. 68 1-2 (1995) 82-84
80. Lejeune J., Gautier M., and Turpin R. Etude des chromosomes somatiques de neuf enfants mongoliens. C. R. Acad. Sci. Paris 248 (1959) 1721-1722
81. Leung A.K., Andersen J.S., Mann M., and Lamond A.I. Bioinformatic analysis of the nucleolus. Biochem. J. 376 3 (2003) 553-569
82. Leung A.K., and Lamond A.I. The dynamics of the nucleolus. Crit. Rev. Eukaryot. Gene 13 1 (2003) 39-54
83. Lezhava T.A. The activity of nucleolar organizer regions of human chromosomes in extreme old age. Gerontology 30 2 (1984) 94-99
84. Lewin B. Genes-VI. P: 211 (1997), Oxford University Press Inc., New York, NY, USA
85. Lindner L.E. Improvements in the silver-staining technique for nucleolar organizer regions (AgNOR). J. Histochem. Cytochem. 41 3 (1993) 439-445
86. Lubec G., and Engidawork E. The brain in Down syndrome (TRISOMY 21). J. Neurol. 249 10 (2002) 1347-1356
87. Luke A., Roizen N.J., Sutton M., and Schoeller D.A. Energy-expenditure in children with down-syndrome-correcting metabolic-rate for movement. J. Pediatrics 125 5 (1994) 829-838
88. Lyle R., Béna F., Gagos S., Gehrig C., Lopez G., Schinzel A., Lespinasse J., Bottani A., Dahoun S., Taine L., Doco-Fenzy M., Cornillet-Lefèbvre P., Pelet A., Lyonnet S., Toutain A., Colleaux L., Horst J., Kennerknecht I., Wakamatsu N., Descartes M., Franklin J.C., Florentin-Arar L., Kitsiou S., Aït Yahya-Graison E., Costantine M., Sinet P.M., Delabar J.M., and Antonarakis S.E. Genotype-phenotype correlations in Down syndrome identified by array CGH in 30 cases of partial trisomy and partial monosomy chromosome 21. Eur. J. Hum. Genet. (2008) doi:10.1038/ejhg.2008.214
89. Mais C., McStay B., and Scheer U. On the formation of amplified nucleoli during early Xenopus oogenesis. J. Struct. Biol. 140 1-3 (2002) 214-226
90. Mao R., Zielke C.L., Zielke H.R., and Pevsner J. Global up-regulation of chromosome 21 gene expression in the developing Down syndrome brain. Genomics 81 5 (2003) 457-467
91. Montanaro L., Treré D., and Derenzini M. Nucleolus, ribosomes, and cancer. Am. J. Pathol. 173 2 (2008) 301-310
92. Moore K.L., and Persaud T.V.N. The Developing Human-Clinically Oriented Embryology (The digestive system). fifth edition (1993), W.B. Saunders Company, Philadelphia, USA p. 237
93. Morimoto Y., Kito S., Ohba T., Morimoto H., Okamura H., and Haneji T. Alteration of argyrophilic nucleolar organizer region associated (Ag-NOR) proteins in apoptosis-induced human salivary gland cells and human oral squamous carcinoma cells. J. Oral. Pathol. Med. 30 4 (2001) 193-199
94. Mrak R.E., and Griffin W.S.T. Trisomy 21 and the brain. J. Neuropathol. Exp. Neurol. 63 7 (2004) 679-685
95. Muller F., Rebiffé M., Taillandier A., Oury J.F., and Mornet E. Parental origin of the extra chromosome in prenatally diagnosed fetal trisomy 21. Hum. Genet. 106 3 (2000) 340-344
96. Mutton D., Alberman E., and Hook E.B. Cytogenetic and epidemiological findings in Down syndrome. England and Wales 1989-1993. National Down Syndrome Cytogenetic Register and the Association of Clinical Cytogeneticists. J. Med. Genet. 33 5 (1996) 387-394
97. Ofner D., and Schmid K.W. Standardized AgNOR analysis: its usefulness in surgical oncology. Histochem. Cell Biol. 106 2 (1996) 193-196
98. O'Leary D.A., Pritchard M.A., Xu D., Kola I., Hertzog P.J., and Ristevski S. Tissue-specific overexpression of the HSA21 gene GABPalpha: implications for DS. Biochim. Biophys. Acta 1739 1 (2004) 81-87
99. Olson L.E., Roper R.J., Sengstaken C.L., Peterson E.A., Aquino V., Galdzicki Z., Siarey R., Pletnikov M., Moran T.H., and Reeves R.H. Trisomy for the Down syndrome 'critical region' is necessary but not sufficient for brain phenotypes of trisomic mice. Hum. Mol. Genet. 16 7 (2007) 774-782
100. Pederson T. The plurifunctional nucleolus. Nucleic Acids Res. 26 17 (1998) 3871-3876
101. Peeters M.A., and Lejeune J. Beneficial effect of 6-mercaptopurine on the mitotic index of trisomy 21 lymphocytes. Implications for future research. Ann. Genet. 32 1 (1989) 21-25
102. Peeters M.A., Megarbane A., Cattaneo F., Rethore M.O., and Lejeune J. Differences in purine metabolism in patients with Down's syndrome. J. Intellect. Disabil. Res. 37 (1993) 491-505
103. Pedrazzini E., Mamaev N., and Slavutsky I. Age related decrease of NOR activity in bone marrow metaphase chromosomes from healthy individuals. Mol. Pathol. 51 1 (1998) 39-42
104. Pession A., Farabegoli F., Trere D., Novello F., Montanaro L., Sperti S., Rambelli F., and Derenzini M. The Ag-NOR proteins and transcription and duplication of ribosomal genes in mammalian-cell nucleoli. Chromosoma 100 4 (1991) 242-250
105. Petersen M.B., Tranebjaerg L., McCormick M.K., Michelsen N., Mikkelsen M., and Antonarakis S.E. Clinical, cytogenetic, and molecular genetic characterization of two unrelated patients with different duplications of 21q. Am. J. Med. Genet. Suppl. 7 (1990) 104-109
106. Pfeiffer R.A., Kessel E.K., and Soer K.H. Partial trisomies of chromosome 21 in man. Two new observations due to translocations 19;21 and 4;21. Clin. Genet. 11 3 (1977) 207-213
107. Ploton D., Menager M., Lechki C., Jeannesson P., Visseaux B., and Adnet J.J. Silver staining of nucleolus organizer regions (NORs). Application to the study of nucleolar structure and value in pathology. Ann. Pathol. 8 3 (1988) 248-252
108. Prandini P., Deutsch S., Lyle R., Gagnebin M., Delucinge Vivier C., Delorenzi M., Gehrig C., Descombes P., Sherman S., Dagna Bricarelli F., Baldo C., Novelli A., Dallapiccola B., and Antonarakis S.E. Natural gene-expression variation in Down syndrome modulates the outcome of gene-dosage imbalance. Am. J. Hum. Genet. 81 2 (2007) 252-263
109. Pritchard M., Reeves R.H., Dierssen M., Patterson D., and Gardiner K.J. Down syndrome and the genes of human chromosome 21: current knowledge and future potentials. Cytogenet. Genome Res. 121 1 (2008) 67-77
110. Rachidi M., Lopes C., Delezoide A.L., and Delabar J.M. C21orf5, a human candidate gene for brain abnormalities and mental retardation in Down syndrome. Cytogenet. Genome Res. 112 1-2 (2006) 16-22
111. Raziuddin S., and Elawad M.E. Immunoregulatory CD4+ CD45R+ suppressor/inducer T lymphocyte subsets and impaired cell-mediated immunity in patients with Down's syndrome. Clin. Exp. Immunol. 79 1 (1990) 67-71
112. Reddy K.S., and Sulcova V. The mobile nature of acrocentric elements illustrated by three unusual chromosome variants. Hum. Genet. 102 6 (1998) 653-662
113. Roat E., Prada N., Ferraresi R., Giovenzana C., Nasi M., Troiano L., Pinti M., Nemes E., Lugli E., Biagioni O., Mariotti M., Ciacci L., Consolo U., Balli F., and Cossarizza A. Mitochondrial alterations and tendency to apoptosis in peripheral blood cells from children with Down syndrome. FEBS Lett. 581 3 (2007) 521-525
114. Ronan A., Fagan K., Christie L., Conroy J., Nowak N.J., and Turner G. Familial 4.3 Mb duplication of 21q22 sheds new light on the Down syndrome critical region. J. Med. Genet. 44 7 (2007) 448-451
115. Roper R.J., and Reeves R.H. Understanding the basis for Down syndrome phenotypes. PLoS Genet. 2 3 (2006) e50
116. Roussel P., Belenguer P., Amalric F., and Hernandez-Verdun D. Nucleolin is an Ag-NOR protein; this property is determined by its amino-terminal domain independently of its phosphorylation state. Exp. Cell Res. 203 1 (1992) 259-269
117. Roussel P., and Hernandez-verdun D. Identification of Ag-NOR proteins, markers of proliferation-related to ribosomal gene activity. Exp. Cell Res. 214 2 (1994) 465-472
118. Roussel P., Andre C., Comai L., and HernandezVerdun D. The rDNA transcription machinery is assembled during mitosis in active NORs and absent in inactive NORs. J. Cell Biol. 133 2 (1996) 235-246
119. Rüschoff J., Plate K., Bittinger A., and Thomas C. Nucleolar organizer regions (NORs). Basic concepts and practical application in tumor pathology. Pathol. Res. Pract. 185 6 (1989) 878-885
120. Seidl R., Bidmon B., Bajo M., Yoo P.C., Cairns N., LaCasse E.C., and Lubec G. Evidence for apoptosis in the fetal Down syndrome brain. J. Child Neurol. 16 6 (2001) 438-442
121. Sirri V., Roussel P., and Hernandez-Verdun D. The AgNOR proteins: qualitative and quantitative changes during the cell cycle. Micron 31 (2000) 121-126
122. Sirri V., Urcuqui-Inchima S., Roussel P., and Hernandez-Verdun D. Nucleolus: the fascinating nuclear body. Histochem. Cell Biol. 129 1 (2008) 13-31
123. Smetana K., Klamová H., Mikulenková D., Pluskalová M., and Hrkal Z. On the nucleolar size and density in human early granulocytic progenitors, myeloblasts. Eur. J. Histochem. 50 2 (2006) 119-124
124. Sørensen P.D., Lomholt B., Frederiksen S., and Tommerup N. Fine mapping of human 5S rRNA genes to chromosome 1q42.11 → q42. 13. Cytogenet. Cell Genet. 57 1 (1991) 26-29
125. Sumner A.T. Nucleolar Organizers (NORs), Chromosome Banding (1990), Unwin Hyman, London, UK pp. 187-205
126. Thomas S., and Mukherjee A.B. A longitudinal study of human age-related ribosomal RNA gene activity as detected by silver-stained NORs. Mech. Ageing Dev. 92 2-3 (1996) 101-109
127. Thiry M. New data concerning the functional organization of the mammalian cell nucleolus: detection of RNA and rRNA by in situ molecular immunocytochemistry. Nucleic Acids Res. 20 23 (1992) 6195-6200
128. Thiry M., and Lafontaine D.L. Birth of a nucleolus: the evolution of nucleolar compartments. Trends Cell Biol. 15 4 (2005) 194-199
129. Timofeeva Mia., Kost M.V., Tikhomirova T.P., Sarafanov A.G., El'bert B.L., Alimov A.A., Kvitsiniia S.L., Beritashvili D.R., and Zelenin A.V. [Organization of a 5S ribosomal RNA gene cluster in the human genome]. Mol. Biol. (Mosk.) 27 4 (1993) 861-868
130. Toyoda A., Noguchi H., Taylor T.D., Ito T., Pletcher M.T., Sakaki Y., Reeves R.H., and Hattori M. Comparative genomic sequence analysis of the human chromosome 21 Down syndrome critical region. Genome Res. 12 9 (2002) 1323-1332
131. Trerè D., Migaldi M., and Trentini G.P. Higher reproducibility of morphometric analysis over the counting method for interphase AgNOR quantification. Anal. Cell. Pathol. 8 1 (1995) 57-65
132. Trerè D. AgNOR staining and quantification. Micron 31 2 (2000) 127-131
133. Vaziri H., Schächter F., Uchida I., Wei L., Zhu X., Effros R., Cohen D., and Harley C.B. Loss of telomeric DNA during aging of normal and trisomy 21 human lymphocytes. Am. J. Hum. Genet. 52 4 (1993) 661-667
134. Wegierski T., Billy E., Nasr F., and Filipowicz W. Bms1p, a G-domain-containing protein, associates with Rcl1p and is required for 18S rRNA biogenesis in yeast. RNA 7 9 (2001) 1254-1267
135. Wolvetang E.J., Bradfield O.M., Hatzistavrou T., Crack P.J., Busciglio J., Kola I., and Hertzog P.J. Overexpression of the chromosome 21 transcription factor Ets2 induces neuronal apoptosis. Neurobiol. Dis. 14 3 (2003) 349-356
136. Yilmaz S.I., and Demirtas H. The increase of NORs expression in buccal mucosa cells of Down's syndrome (trisomy 21) infants. Chromosome Res. 15 Suppl. 1 (2007) 86
137. Yilmaz S.I., and Demirtas H. AgNOR increase in buccal epithelial cells of trisomy 21 infants. Micron 39 8 (2008) 1262-1265
138. Yoon P.W., Freeman S.B., Sherman S.L., Taft L.F., Gu Y., Pettay D., Flanders W.D., Khoury M.J., and Hassold T.J. Advanced maternal age and the risk of Down syndrome characterized by the meiotic stage of chromosomal error: a population-based study. Am. J. Hum. Genet. 58 3 (1996) 628-633